Results 191 to 200 of about 642,073 (244)

Mucinous Carcinoma, Mucinous Borderline Tumor and Pseudomyxoma Ovarii in a Cystic Teratoma: A Histological Conundrum. [PDF]

Diagnostics (Basel)
Giacometti C, Mirandola M, Aliberti C, Molinari F, Marcolini L, Mautone D, Martignoni G.   +6 more
europepmc   +1 more source

Radiological Tumor Calcification in Sinonasal Adenocarcinoma: Prevalence and Prognostic Implications

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
Radiological intratumoral calcifications in sinonasal adenocarcinoma have been scarcely investigated. This study aimed to assess their prevalence and evaluate their potential prognostic significance and to examine its association with surgical resectability. ABSTRACT Objective(s) Radiological intratumoral calcifications in sinonasal adenocarcinoma have
Julia Fanchette, Florian Chatelet, Melania Bertolini, B. Boukebous, Alessandro Vinciguerra, Martina Conti, Jean Pierre Guichard, Khaled Al Tabaa, Michel Wassef, Homa Adle‐Biassette, Philippe Herman, Benjamin Verillaud   +11 more
wiley   +1 more source

Deceptive appearance of primary mucinous carcinoma of the eyelid: A rare case and literature review. [PDF]

Rom J Ophthalmol
Kumar SV, Madakshira MG, Kumar V, Mishra SK, Sati A, Kumar NV.   +5 more
europepmc   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Race as a prognostic factor of breast mucinous carcinoma. [PDF]

J Cancer Res Clin Oncol
Wang D, Wang Y, Gao S, Zheng R, Wu G, Wang J, Lu C, Bu K, Zhang C, Chen W, Zhang B.   +10 more
europepmc   +1 more source

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer

MedComm, Volume 7, Issue 10, October 2026.
Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta, Ramakrishna Vadde, Ganji Purnachandra Nagaraju   +2 more
wiley   +1 more source

Gastric metastasis arising from invasive ductal and mucinous carcinoma of the breast: a case report and literature review. [PDF]

Front Oncol
Lyu Z, Fei J, Zhang L, Liu Y.
europepmc   +1 more source

Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management

MedComm, Volume 7, Issue 10, October 2026.
Colorectal cancer is a heterogeneous, adaptive disease shaped by population‐level risk, genomic and epigenetic alterations, tumor ecosystem evolution, and treatment pressure. This review integrates epidemiology, risk factors, signaling networks, clinical presentation, screening, molecular diagnosis, and stage‐ and biomarker‐guided management while ...
Kairui Wan, Ke Tang, Linglong Wang, Qin Tian, Mingwei Zheng, Cheng Qian, Limei Liu   +6 more
wiley   +1 more source

Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases

MedComm, Volume 7, Issue 10, October 2026.
BTK inhibitors suppress malignant B‐cell signaling while simultaneously reshaping immune regulation through effects on T cells and the tumor microenvironment. These mechanisms support combination immunotherapy strategies and also underlie the expanding application of BTK inhibitors in solid tumors, autoimmune and inflammatory diseases.
Miao Sun, Dengju Li, Jia Wei
wiley   +1 more source

Analysis of survival and prognostic factors in appendix adenocarcinoma and mucinous carcinoma. [PDF]

Updates Surg
Turan B, Sanli AN, Acar S.
europepmc   +1 more source